MEDICUS PHARMA LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.67 CAD | -1.76% |
|
-5.65% | -16.50% |
| 05-29 | Medicus Pharma Files Registration Statement for Proposed Initial Public Offering in the United States | MT |
| 04-25 | Medicus Pharma Ltd. announced a financing transaction | CI |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Capitalization 1 | 26.98 | 26.98 | - |
| Enterprise Value (EV) 1 | 26.98 | 26.98 | 26.98 |
| P/E ratio | - | - | - |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | - | - | - |
| EV / FCF | - | -37.2 x | -35.2 x |
| FCF Yield | - | -2.68% | -2.84% |
| Price to Book | - | - | - |
| Nbr of stocks (in thousands) | 16,153 | 16,153 | - |
| Reference price 2 | 1.670 | 1.670 | 1.670 |
| Announcement Date | - | - | - |
1CAD in Million2
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net sales 1 | - | - | - |
| EBITDA | - | - | - |
| EBIT | - | - | - |
| Operating Margin | - | - | - |
| Earnings before Tax (EBT) | - | - | - |
| Net income | - | - | - |
| Net margin | - | - | - |
| EPS | - | - | - |
| Free Cash Flow | - | -724,224 | -766,435 |
| FCF margin | - | - | - |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | - | - | - |
1CAD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Debt | - | - | - |
| Net Cash position | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow | - | -724,224 | -766,435 |
| ROE (net income / shareholders' equity) | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - |
| Assets | - | - | - |
| Book Value Per Share | - | - | - |
| Cash Flow per Share | - | - | - |
| Capex | - | - | - |
| Capex / Sales | - | - | - |
| Announcement Date | - | - | - |
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.50% | 19.75M | |
| +55.19% | 815B | |
| +45.37% | 654B | |
| -6.09% | 354B | |
| +21.92% | 337B | |
| +19.59% | 247B | |
| +3.52% | 229B | |
| +14.02% | 219B | |
| +10.86% | 171B | |
| -2.78% | 159B |
- Stock Market
- Equities
- MDCX Stock
- Financials Medicus Pharma Ltd.
